Mark Mallon - 30 Dec 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Chief Executive Officer, Director
Signature: /s/ Mark W. Mallon
Issuer symbol: NEO
Transactions as of: 30 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 30 Dec 2021, 17:05:03 UTC
Previous filing: 06 Dec 2021
Next filing: 03 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Award	$0	+152,858	+210%	$0.000000	225,594	30 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NEO	Stock Option (Right to Buy)						151,016	30 Dec 2021	Common Stock	151,016	$49.34	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 30, 2021, Mr. Mallon was granted 152,858 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
F2	On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.